An Evaluation of Treatment Patterns and Associated Outcomes Among Adult Hospitalized Patients With Lower-Risk Community-Acquired Complicated Intra-abdominal Infections: How Often Are Expert Guidelines Followed?
cIAI
infection
outcomes
treatment
Journal
Open forum infectious diseases
ISSN: 2328-8957
Titre abrégé: Open Forum Infect Dis
Pays: United States
ID NLM: 101637045
Informations de publication
Date de publication:
Jul 2020
Jul 2020
Historique:
received:
31
03
2020
accepted:
12
06
2020
entrez:
18
7
2020
pubmed:
18
7
2020
medline:
18
7
2020
Statut:
epublish
Résumé
Expert guidelines discourage use of antipseudomonal β-lactams and fluoroquinolones in lower-risk patients with community-acquired complicated intra-abdominal infection (CA cIAI). Compliance with these recommendations across US hospitals is unclear. This study sought to determine treatment patterns and associated outcomes among adult hospitalized lower-risk patients with CA cIAI. A study using data from the Premier Healthcare Database (10/2015-12/2017) was performed. Inclusion criteria: age ≥18 years; hospitalized; had a cIAI at admission; and received antibiotics within the first 4 hospital days. Patients were excluded if they were high risk, were transferred from another health care facility, had a recent hospital admission, or received dialysis within 30 days of admission. Empiric antibiotic treatment patterns and associated outcomes were quantified. Overall, 46 Overuse of antipseudomonal β-lactams and fluoroquinolones was commonplace among lower-risk CA IAI patients. These findings can serve as the basis for an antimicrobial stewardship initiative in hospitals aspiring to reduce the use of broad-spectrum antibiotics.
Sections du résumé
BACKGROUND
BACKGROUND
Expert guidelines discourage use of antipseudomonal β-lactams and fluoroquinolones in lower-risk patients with community-acquired complicated intra-abdominal infection (CA cIAI). Compliance with these recommendations across US hospitals is unclear. This study sought to determine treatment patterns and associated outcomes among adult hospitalized lower-risk patients with CA cIAI.
METHODS
METHODS
A study using data from the Premier Healthcare Database (10/2015-12/2017) was performed. Inclusion criteria: age ≥18 years; hospitalized; had a cIAI at admission; and received antibiotics within the first 4 hospital days. Patients were excluded if they were high risk, were transferred from another health care facility, had a recent hospital admission, or received dialysis within 30 days of admission. Empiric antibiotic treatment patterns and associated outcomes were quantified.
RESULTS
RESULTS
Overall, 46
CONCLUSIONS
CONCLUSIONS
Overuse of antipseudomonal β-lactams and fluoroquinolones was commonplace among lower-risk CA IAI patients. These findings can serve as the basis for an antimicrobial stewardship initiative in hospitals aspiring to reduce the use of broad-spectrum antibiotics.
Identifiants
pubmed: 32676511
doi: 10.1093/ofid/ofaa237
pii: ofaa237
pmc: PMC7353956
doi:
Types de publication
Journal Article
Langues
eng
Pagination
ofaa237Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.
Références
Clin Infect Dis. 2017 Aug 15;65(4):613-618
pubmed: 28444166
Infect Control Hosp Epidemiol. 2007 Aug;28(8):959-65
pubmed: 17620244
J Microbiol Immunol Infect. 2018 Jun;51(3):359-366
pubmed: 28988663
JAMA Surg. 2017 Mar 1;152(3):224-232
pubmed: 27851857
Surg Infect (Larchmt). 2019 Dec;20(8):650-657
pubmed: 31464573
World J Emerg Surg. 2014 May 14;9:37
pubmed: 24883079
Clin Infect Dis. 2018 Mar 19;66(7):e1-e48
pubmed: 29462280
Clin Infect Dis. 2010 Oct 15;51(8):895-903
pubmed: 20839951
J Chemother. 2015 Feb;27(2):67-73
pubmed: 24548089
Clin Infect Dis. 2010 Jan 15;50(2):133-64
pubmed: 20034345
Open Forum Infect Dis. 2019 Nov 04;6(12):ofz475
pubmed: 31844636
Surg Infect (Larchmt). 2017 Jan;18(1):1-76
pubmed: 28085573
Open Forum Infect Dis. 2019 Nov 25;6(12):ofz504
pubmed: 31858017
J Clin Med. 2019 Jun 17;8(6):
pubmed: 31212991
Pharmacotherapy. 2019 Mar;39(3):261-270
pubmed: 30506852
J Antimicrob Chemother. 2014 Apr;69(4):1127-31
pubmed: 24327619
Int J Surg. 2010;8(6):426-9
pubmed: 20621208
J Trauma Acute Care Surg. 2012 Mar;72(3):691-5
pubmed: 22491554
Clin Infect Dis. 2016 May 15;62(10):e51-77
pubmed: 27080992
J Chronic Dis. 1987;40(5):373-83
pubmed: 3558716
Clin Infect Dis. 2019 Aug 30;69(6):921-929
pubmed: 30561562
J Antimicrob Chemother. 2011 Jul;66(7):1600-8
pubmed: 21508008
Arch Intern Med. 2012 Jun 25;172(12):922-8
pubmed: 22732747
Clin Infect Dis. 2019 Aug 1;69(4):604-613
pubmed: 30383203